Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Stock price

Equities

603168

CNE100001TG0

Pharmaceuticals

End-of-day quote Shanghai S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
10.21 CNY +0.39% Intraday chart for Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. -3.50% -23.86%
Sales 2021 627M 86.86M Sales 2022 550M 76.12M Capitalization 3.4B 471M
Net income 2021 35M 4.85M Net income 2022 45M 6.23M EV / Sales 2021 4.55 x
Net cash position 2021 206M 28.52M Net cash position 2022 515M 71.28M EV / Sales 2022 5.25 x
P/E ratio 2021
86.2 x
P/E ratio 2022
65.7 x
Employees 1,241
Yield 2021 *
-
Yield 2022
0.41%
Free-Float 45.17%
More Fundamentals * Assessed data
Dynamic Chart
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shanghai Lechun Biotechnology Co., Ltd. sign a share transfer agreement to acquire a 14.5% stake in Advanced Sterile Solutions Biotechnology Co., Ltd. from Shanghai Changgeng Industrial Development Co., Ltd. and Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. for CNY 40.6 million. CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Taizhou Women and Children's Hospital Co., Ltd. announced that it expects to receive CNY 231.1828 million in funding from Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. agreed to acquire Qingdao Shikang Eye Hospital Co., Ltd. from Shanghai Fangzhi Medical Management Co., Ltd. for CNY 66.5 million CI
Zhejiang Shapuaisi Pharma Shareholder Boosts Stake Through $44 Million Deal MT
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. announced that it has received CNY 317.999993 million in funding from Shanghai Yanghe Investment Management Co., Ltd. and other investor. CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. announced that it expects to receive funding from Shanghai Yanghe Industrial Co., Ltd. CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
More news
1 day+0.39%
1 week-3.50%
Current month+10.98%
1 month+15.24%
3 months-16.24%
6 months+3.55%
Current year-23.86%
More quotes
1 week
9.75
Extreme 9.75
10.66
1 month
9.16
Extreme 9.16
11.20
Current year
7.09
Extreme 7.09
14.04
1 year
7.09
Extreme 7.09
15.80
3 years
6.17
Extreme 6.17
15.80
5 years
5.55
Extreme 5.55
15.80
10 years
5.55
Extreme 5.55
56.70
More quotes
Managers TitleAgeSince
Chief Executive Officer 42 20-08-27
Director of Finance/CFO 55 20-12-16
Director/Board Member 30 23-05-18
Members of the board TitleAgeSince
Director/Board Member 67 20-08-27
Director/Board Member 73 10-04-01
Director/Board Member 58 -
More insiders
Date Price Change Volume
24-03-28 10.21 +0.39% 19,106,630
24-03-27 10.17 0.00% 22,205,350
24-03-26 10.17 +1.90% 15,425,720
24-03-25 9.98 -3.57% 22,765,150
24-03-22 10.35 -2.17% 23,891,400

End-of-day quote Shanghai S.E., March 27, 2024

More quotes
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. is a China-based company principally engaged in the production, research, development and sale of chemical medicine and Chinese patent drugs. The Company's chemical medicine products mainly include Shapuaisi Bendazac Lysine Eye Drops, infusion products and cefixime products. The Company's Chinese patent drugs include kidney tonifying and nerve soothing products, such as Sizi Tianjing Capsules and Compound Gaoshan Hongjingtian Solution. The Company distributes its products in domestic market.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. - Shanghai S.E.